Mohsen, Mona O

MacLean, Andrew J; Bonifacio, Joao P P L; Oram, Sophia L; Mohsen, Mona O; Bachmann, Martin F; Arnon, Tal I (2024). Regulation of pulmonary plasma cell responses during secondary infection with influenza virus. The Journal of experimental medicine, 221(7) Rockefeller Univ. Press 10.1084/jem.20232014

Sobczak, Jan M; Barkovska, Irena; Balke, Ina; Rothen, Dominik A; Mohsen, Mona O; Skrastina, Dace; Ogrina, Anete; Martina, Byron; Jansons, Juris; Bogans, Janis; Vogel, Monique; Bachmann, Martin F; Zeltins, Andris (2024). Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response. Vaccines, 12(6) MDPI 10.3390/vaccines12060661

Josi, Romano; Speiser, Daniel E; de Brot, Simone; Vogt, Anne-Cathrine; Sevick-Muraca, Eva M; Tolstonog, Genrich V; Bachmann, Martin F; Mohsen, Mona O (2024). A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activation. iScience, 27(4) Elsevier 10.1016/j.isci.2024.109439

Sobczak, Jan M; Krenger, Pascal S; Storni, Federico; Mohsen, Mona O; Balke, Ina; Reseviča, Gunta; Heath, Matthew D; Carreno Velazquez, Thalia L; Kramer, Matthias F; Scott, Callum J W; Skinner, Murray A; Zeltiņš, Andris; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin F (2023). The next generation virus-like particle platform for the treatment of peanut allergy. Allergy, 78(7), pp. 1980-1996. Wiley-Blackwell 10.1111/all.15704

Vogt, Anne-Cathrine S; Jennings, Gary T; Mohsen, Mona O; Vogel, Monique; Bachmann, Martin F (2023). Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β. International journal of molecular sciences, 24(4) MDPI 10.3390/ijms24043895

Chang, Xinyue; Liu, Xuelan; Martina, Byron; Zeltins, Andris; Augusto, Gilles; Vogel, Monique; Mohsen, Mona O; Speiser, Daniel E; Bachmann, Martin F (2023). Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation. Frontiers in immunology, 14(1114396), p. 1114396. Frontiers Research Foundation 10.3389/fimmu.2023.1114396

Fernandes, Queenie; Inchakalody, Varghese Philipose; Merhi, Maysaloun; Mestiri, Sarra; Taib, Nassiba; Moustafa Abo El-Ella, Dina; Bedhiafi, Takwa; Raza, Afsheen; Al-Zaidan, Lobna; Mohsen, Mona O; Yousuf Al-Nesf, Mariam Ali; Hssain, Ali Ait; Yassine, Hadi Mohamad; Bachmann, Martin F; Uddin, Shahab; Dermime, Said (2022). Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Annals of medicine, 54(1), pp. 524-540. Taylor & Francis 10.1080/07853890.2022.2031274

Mohsen, Mona O; Bachmann, Martin F (2022). Virus-like particle vaccinology, from bench to bedside. Cellular & molecular immunology, 19(9), pp. 993-1011. Nature Publ. Group 10.1038/s41423-022-00897-8

Mohsen, Mona O; Heath, Matthew; Kramer, Matthias F; Velazquez, Thalia Carreno; Bullimore, Alan; Skinner, Murray A; Speiser, Daniel E; Bachmann, Martin F (2022). In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma. Journal for immunotherapy of cancer, 10(9) BioMed Central 10.1136/jitc-2022-004643

Rothen, Dominik A; Krenger, Pascal S; Nonic, Aleksandra; Balke, Ina; Vogt, Anne-Cathrine S; Chang, Xinyue; Manenti, Alessandro; Vedovi, Fabio; Resevica, Gunta; Walton, Senta M; Zeltins, Andris; Montomoli, Emanuele; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern. Allergy, 77(8), pp. 2446-2458. Wiley 10.1111/all.15311

Vogt, Anne-Cathrine S; Jörg, Lukas; Martina, Byron; Krenger, Pascal S; Chang, Xinyue; Zeltins, Andris; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin F (2022). Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies. Frontiers in immunology, 13, p. 864718. Frontiers Research Foundation 10.3389/fimmu.2022.864718

Bachmann, Martin F; Mohsen, Mona O; Speiser, Daniel E (2022). Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism. NPJ vaccines, 7(1), p. 56. Springer Nature 10.1038/s41541-022-00479-9

Vogt, Anne-Cathrine S; Augusto, Gilles; Martina, Byron; Chang, Xinyue; Nasrallah, Gheyath; Speiser, Daniel E; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron. Vaccines, 10(5) MDPI 10.3390/vaccines10050743

Bachmann, Martin F; Mohsen, Mona O; Speiser, Daniel E (2022). The Future of SARS-CoV-2 Vaccination. The New England journal of medicine, 386(9), pp. 899-900. Massachusetts Medical Society 10.1056/NEJMc2119437

Chang, Xinyue; Liu, Xuelan; Mohsen, Mona O; Zeltins, Andris; Martina, Byron; Vogel, Monique; Bachmann, Martin F (2022). Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles. Vaccines, 10(2) MDPI 10.3390/vaccines10020307

Chang, Xinyue; Krenger, Pascal; Krüger, Caroline C; Zha, Lisha; Han, Jiami; Yermanos, Alexander; Roongta, Salony; Mohsen, Mona O; Oxenius, Annette; Vogel, Monique; Bachmann, Martin F (2022). TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization. Frontiers in immunology, 12, p. 827256. Frontiers Research Foundation 10.3389/fimmu.2021.827256

Mohsen, Mona O; Speiser, Daniel E; Michaux, Justine; Pak, HuiSong; Stevenson, Brian J; Vogel, Monique; Inchakalody, Varghese Philipose; De Brot, Simone; Dermime, Said; Coukos, Georges; Bassani-Sternberg, Michal; Bachmann, Martin F (2022). Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma. Journal for immunotherapy of cancer, 10(1) BMJ Publishing Group 10.1136/jitc-2021-002927

Chang, Xinyue; Sousa Augusto, Gilles; Liu, Xuelan; Kündig, Thomas M; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin (2021). BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy, 76(9), pp. 2895-2998. Wiley 10.1111/all.14893

Chang, Xinyue; Zha, Lisha; Wallimann, Alexandra; Mohsen, Mona O; Krenger, Pascal; Liu, Xuelan; Vogel, Monique; Bachmann, Martin F (2021). Low-affinity but high-avidity interactions may offer an explanation for IgE-mediated allergen cross-reactivity. Allergy, 76(8), pp. 2565-2574. Wiley 10.1111/all.14864

Heath, Matthew D; Mohsen, Mona O; de Kam, Pieter-Jan; Carreno Velazquez, Thalia L; Hewings, Simon J; Kramer, Matthias F; Kündig, Thomas M; Bachmann, Martin F; Skinner, Murray A (2020). Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in immunology, 11, p. 594911. Frontiers Research Foundation 10.3389/fimmu.2020.594911

Mohsen, Mona O; Gomes, Ariane C; Cabral-Miranda, Gustavo; Krüger, Caroline Claire; Leoratti, Fabiana M S; Stein, Jens Volker; Bachmann, Martin (2017). Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. Journal of controlled release, 251, pp. 92-100. Elsevier 10.1016/j.jconrel.2017.02.031

Zha, Lisha; He, Lichun; Xie, Weidong; Cheng, Jin; Li, Tong; Mohsen, Mona O; Lei, Fan; Storni, Federico Lorenzo; Bachmann, Martin; Chen, Hongquan; Zhang, Yaou (2017). Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis. PLoS ONE, 12(5), e0177964. Public Library of Science 10.1371/journal.pone.0177964